标题:CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to Erlotinib via transcriptional regulation of EGFR
作者:Wang, Yunshan; Zhang, Pengju; Liu, Ziming; Wang, Qin; Wen, Mingxin; Wang, Yuli; Yuan, Hongtu; Mao, Jian-Hua; Wei, Guangwei
作者机构:[Wang, Yunshan; Wen, Mingxin; Wang, Yuli; Wei, Guangwei] Shandong Univ, Sch Med, Minist Educ, Dept Anat, Jinan 250012, Shandong, Peoples R China.; [ 更多
通讯作者:Wei, GW
通讯作者地址:[Wei, GW]Shandong Univ, Sch Med, Minist Educ, Dept Anat, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.
来源:MOLECULAR CANCER
出版年:2014
卷:13
DOI:10.1186/1476-4598-13-252
关键词:CUL4A; Lung cancer; EGFR; Erlotinib
摘要:Background: CUL4A has been proposed as oncogene in several types of human cancer, but its clinical significance and functional role in human non-small cell lung cancer (NSCLC) remain unclear.; Methods: Expression level of CUL4A was examined by RT-PCR and Western blot. Forced expression of CUL4A was mediated by retroviruses, and CUL4A silencing by shRNAs expressing lentiviruses. Growth capacity of lung cancer cells was measured by MTT in vitro and tumorigenesis in vivo, respectively.; Results: We found that CUL4A was highly expressed in human lung cancer tissues and lung cancer cell lines, and this elevated expression positively correlated with disease progression and prognosis. Overexpression of CUL4A in human lung cancer cell lines increased cell proliferation, inhibited apoptosis, and subsequently conferred resistance to chemotherapy. On other hand, silencing CUL4A expression in NSCLC cells reduced proliferation, promoted apoptosis and resulted in tumor growth inhibition in cancer xenograft model. Mechanistically, we revealed CUL4A regulated EGFR transcriptional expression and activation, and subsequently activated AKT. Targeted inhibition of EGFR activity blocked these CUL4A induced oncogenic activities.; Conclusions: Our results highlight the significance of CUL4A in NSCLC and suggest that CUL4A could be a promising therapy target and a potential biomarker for prognosis and EGFR target therapy in NSCLC patients.
收录类别:SCOPUS;SCIE
WOS核心被引频次:33
Scopus被引频次:35
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84934991979&doi=10.1186%2f1476-4598-13-252&partnerID=40&md5=317acfa9db58eaf640f68d991b880394
TOP